Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Immune memory induction is a fundamental biological process of the adaptive immune system rather than a single molecular target, receptor, or enzyme [1][2]. It describes the mechanism by which the immune system, upon exposure to an antigen, generates long-lived memory T and B cells that provide rapid and robust protection against subsequent encounters with the same pathogen or malignant cell population [3]. This process is the primary physiological basis for vaccination and involves a complex orchestration of antigen presentation, co-stimulatory signaling (such as CD28 or CD40), and cytokine-driven differentiation [4]. While therapeutic agents like vaccines and checkpoint inhibitors aim to induce or enhance immune memory, the term refers to a coordinated systemic outcome rather than a discrete protein or targetable molecule [5].
The process involves the activation of naive B and T lymphocytes by antigens and co-stimulatory signals, leading to their differentiation into long-lived memory cells that persist in the absence of the original stimulus.
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Immune memory induction.